1 Hinchey J，Chaves C，Appignani B，et al. Reversible

posterior leukoencephalopathy syndrome[J]. N Engl

Med，1996，334：494-500.

2 Baizabal-Carvallo JF，Bar ragán-Campos HM，

Padilla-Aranda HJ，et al. Poster ior reversible

encephalopathy syndrome as a complication of lupus

activity[J]. Clin Neurol Neurosurg，2009，111：359-

363.

3 van Beers EJ1，Stam J，van den Bergh WM. Licorice

consumption as a cause of posterior reversible

encephalopathy syndrome：a case report[J]. Critical

Care，2011，15：R64，doi：10.1186/cc10040.

4 Feske SK. Posterior reversible encephalopathy

syndrome：a review[J]. Semin Neurol 2011，31：202-

215.

5 Lima n TG，Boh ner G，Heuschman n PU，e t

al. The clinical and radiological spect rum of

posterior reversible encephalopathy syndrome：the

retrospective Berlin PRES study[J]. J Neurol，2012，

259：155-164.

6 Lee VH，Wijdicks EF，Manno EM，et al. Clinical

spectrum of reversible posterior leukoencephalopathy syndrome[J]. Arch Neurol，2008，65：205-210.

7 MacKenzie ET，Strandgaard S，Graham DI，et al.

Effects of acutely induced hypertension in cats on pial

arteriolar caliber，local cerebral blood flow，and the

blood-brain barrier[J]. Circ Res，1976，39：33-41.

8 Ha n s s o n HA，Johans son B，Bloms t r and C.

Ultrastructural studies on cerebrovascular permeability

in acute hypertension[J]. Acta Neuropathol，1975，32：

187-198.

9 Byrom FB. The pathogenesis of hyper tensive

encephalopathy and its relation to the malignant phase

of hypertension; experimental evidence from the

hypertensive rat[J]. Lancet，1954，267：201-211.

10 Tama k i K，Sadosh ima S，Baumbach GL，e t

al. Evidence that disruption of the blood-brain

barrier precedes reduction in cerebral blood flow in

hypertensive encephalopathy[J]. Hypertension，1984，

6：175-181.

11 Schwartz RB，Mulkern RV，GudbjartssonH，et al.

Diffusion-weighted MR imaging in hypertensive

encephalopathy：clues to pathogenesis[J]. AJNR Am J

Neuroradiol，1998，19：859-862.

12 Ba r t y nsk i WS，Boardman JF，Zeigler ZR，et

al. Posterior reversible encephalopathy syndrome

in infection，sepsis，and shock[J]. AJNR Am J

Neuroradiol，2006，27：2179-2190.

13 Zhao ZY，He F，Gao PH，et al. Blood transfusionrelated

poster ior rever sible encephalopathy

syndrome[J]. J Neurol Sci，2014，342：124.

14 Gopalakrishnan CV，Vikas V，Nair S. Posterior

reversible encephalopathy syndrome in a case of

postoperative spinal extradural haematoma：case

report and review of literature[J]. Asian Spine J，2011，

5：64-67.

15 Fugate JE，Claassen DO，Cloft HJ. Poster ior

reversible encephalopathy syndrome：associated

clinical and radiologic findings[J]. Mayo Clinic Proc，

2010，85：427-432.

16 Harirchian MH，Ghaffarpour M，Tabaeizadeh M，et

al. Immunosuppressive drugs，an emerging cause of

posterior reversible encephalopathy syndrome：case

series[J]. J Stroke Cerebrovasc Dis，24：e191-e195.

17 Sh a Z，Mo r a n BP，McKi n n e y AM 4 t h，e t

al. Seizure outcomes of poster ior reversible

encephalopathy syndrome and correlations with

elect roencephalographic changes[J]. Epilepsy

Behavior，2015，48：70-74.

18 Fugate JE，Rabinstein AA. Rabinstein. Posterior

reversible encephalopathy syndrome：clinical and

adiological manifestations，pathophysiology，and

outstanding questions[J]. Lancet Neurol，2015，14：914-925.

19 Neeb L，Hoekstra J，Endres M，et al. Spectrum of

cerebral spinal fluid findings in patients with posterior

reversible encephalopathy syndrome[J]. J Neurol，

2015-10-17[Epub ahead of print].

20 Bo G，Hui L，Feng-Li L，et al. Relationships

between edema degree and clinical and biochemical

parameters in posterior reversible encephalopathy

syndrome：a preliminary study[J]. Acta Neurol Belg，

2012，112：281-285.

21 Granata G，Greco A，Iannella G，et al. Posterior

reversible encephalopathy syndrome—Insight

into pathogenesis，clinical variants and treatment

approaches[J]. Autoimmun Rev，2015，14：830-836.

22 McKinney AM，Short J，Truwit CL，et al. Posterior

reversible encephalopathy syndrome：incidence of

atypical regions of involvement and imaging findings[J].

AJR Am J Roentgenol，2007，189：904-912.

23 Ibrahim NMA，Badawy ME. MRI imaging of

posterior reversible encephalopathy syndrome

associated with pregnancy[J]. Egypt J Radiol Nucl

Med，2014，45：505-510.

24 Lima n TG，Boh ner G，Heuschman n PU，e t

al. The clinical and radiological spect rum of

posterior reversible encephalopathy syndrome：the

retrospective Berlin PRES study[J]. J Neurol，2012，

259：155-164.

25 Mancia G，Fagard R，Narkiewicz K，et al. 2013

ESH/ESC guidelines for the management of arterial

hypertension：the task force for the management

of arterial hypertension of the European Society of

Hypertension (ESH) and of the European Society of

Cardiology (ESC)[J]. Eur Heart J，2013，34：2159-2219.

26 Li R，Mitchell P，Dowling R，et al. Is hypertension

predictive of clinical recurrence in posterior reversible

encephalopathy syndrome?[J]. J Clin Neurosci，2013，

20：248-252.

27 Schwartz RB，Feske SK，Polak JF，et al. Preeclampsia

eclampsia：clinical and neuroradiographic correlates

and insights into the pathogenesis of hypertensive

encephalopathy[J]. Radiology，2000，217：371-376.

28 Zeeman GG. Neurologic complications of preeclampsia[

J]. Semin Perinatol，2009，33：166-172.

29 Sibai BM，Eclampsia VI. Maternal-perinatal outcome

in 254 consecutive cases[J]. Am J Obstet Gynecol，

1990，163：1049-1055.

30 Brewer J，Owens MY，Wallace K，et al. Posterior

reversible encephalopathy syndrome in 46 of 47

patients with eclampsia[J]. Am J Obstet Gynecol，

2013，208：468，e1-6.

31 Kurdoglu Z，Cetin O，Say?n R，et al. Clinical and perinatal outcomes in eclamptic women with posterior

reversible encephalopathy syndrome[J]. Arch Gynecol

Obstet，2015，292：1013-1018.

32 Euser AG，Cipolla MJ. Magnesium sulfate for the

treatment of eclampsia：a brief review[J]. Stroke，

2009，40：1169-1175.

33 Tsukimori K，Ochi H，Yumoto Y，et al. Reversible

posterior encephalopathy syndrome followed by

MR angiography-documented cerebral vasospasm

in preeclampsia-eclampsia：report of 2 cases[J].

Cerebrovasc Dis，2008，25：377-380.

34 Tan JL，McClure J，Hennington L，et al. The heat

is on：a case of hyperthermia-induced posterior

reversible encephalopathy syndrome (PRES)[J].

Neurol Sci，2014，35：127-130.

35 Zuccoli G，Nardone R，Hoda AH. Guillain Barré

syndrome-related posterior reversible encephalopathy

syndrome[J]. Neuroradiology，2015，57：755-756.

36 Ogunneye O，Hernandez-Montfort JA，Ogunneye Y.

Parainfluenza virus infection associated with posterior

reversible encephalopathy syndrome：a case report[J].

J Med Case Rep，2012，6：89.

37 Donmez FY. Guillain Bar ré syndrome-related

posterior reversible encephalopathy syndrome[J].

Neuroradiology，2015，57：863-864.

38 Bartynski WS. Posterior reversible encephalopathy

syndrome，par t 2：cont roversies sur rounding

pathophysiology of vasogenic edema[J]. AJNR Am J

Neuroradiol，2008，29：1043-1049.

39 Sweany JM，Bartynski WS，Boardman JF. Recurrent

posterior reversible encephalopathy syndrome，report

of 3 cases—PRES can strike twice[J]. J Comput

Assist Tomogr，2007，31：148-156.

40 Bartynski WS. Posterior reversible encephalopathy

syndrome part 1：fundamental imaging and clinical

features[J]. AJNR Am J Neuroradiol，2008，29：1036-

1042.

41 Pr uit t JH，Copeland EM 3rd，Moldawer LL.

Interleukin-1 and interleukin-1 antagonism in sepsis，

systemic inf lammatory response syndrome，and

septic shock[J]. Shock，1995，3：235-251.

42 Cozzolino M，Bianchi C，Mariani G，et al. Therapy

and differential diagnosis of posterior reversible

encephalopathy syndrome (PRES) during pregnancy

and postpartum[J]. Arch Gynecol Obstet，2015，292：

1217-1223.

43 Martins WA，Marrone LC. Malignant posterior

reversible encephalopathy syndrome：A case posterior

irreversible encephalopathy syndrome[J]. J Clin

Neurol，2015-11-44[Epub ahead of print].

44 Hefzy HM，Bartynski WS，Boardman JF，et al. Hemorrhage in posterior reversible encephalopathy

syndrome：imaging and clinical features[J]. AJNR

Am J Neuroradiol，2009，30：1371-1379.

45 Alhilali LM，Reynolds AR，Fakhran S. A multidisciplinary

model of risk factors for fatal outcome

in posterior reversible encephalopathy syndrome[J]. J

Neurol Sci，2014，347:59-65.